Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Vaccines
•
Allergy & Immunology
Why are influenza and COVID vaccines still recommended for patients on immunoglobulin replacement therapy?
Related Questions
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How do you manage introduction of other seeds when the patient has never been exposed and has a sesame allergy?
What functional assays do you recommend to determine if MGRPRX2 receptor activation has led to a non-IgE mediated anaphylaxis?
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?
